<i id='7DA492A328'><strike id='7DA492A328'><tt id='7DA492A328'><pre id='7DA492A328'></pre></tt></strike></i> 
WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.
In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.
advertisement
“Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
GET STARTED Log In
Peter Hotez and the public health issue of online harassment 
The future of health care in the House 
Sports medicine is finally prioritizing gender equality 
Wellcome Trust names Røttingen as its new CEO 
Medical records are filled with copy 
Was Amgen transparent enough on FDA's concern on cancer drug? 
Cancer drug shortages should be causing more outrage 
European regulators consider appeal over Amylyx ALS drug 
Bright Health sells Medicare Advantage business to Molina 
A revolution in caring for preterm infants 
Tori Bowie and the unacceptable rates of Black maternal death 
In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati 
What does generative AI mean for health care? We asked experts 
Why Charlie Gard's case is so disturbing to Americans
Cancer drug shortages should be causing more outrage 
